Skip to main content
Retour
Watch Compare

Drugs Made In America Acquisition Corp.

Qualité des données : 83%
Également cotée sous DMAAU Nasdaq DMAAR Nasdaq
DMAA
Nasdaq Financial Services Holding & Investment Offices
10,52 €
0,00 € (0,00%)
Cap. Boursière: 352,43 M
Prix
10,52 €
Cap. Boursière
352,43 M
Fourchette du Jour
10,52 € — 10,52 €
Fourchette 52 Semaines
10,03 € — 10,52 €
Volume
17
Ouverture 10,51 €
Moyenne 50J / 200J
10,46 €
0,50% above
Moyenne 50J / 200J
10,34 €
1,72% above

Quick Summary

Points Clés

Negative free cash flow of -586 272,0
P/E of 64,69 — premium valuation

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio0,06
Interest CoverageN/A

Valorisation

PE (TTM)
64,69
Au-dessus de la moyenne du secteur (11,15)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Financial Services (2151 pairs)
Métrique Action Médiane du Secteur
P/E 64,7 11,2
P/B — 1,2
ROE % — 9,2
Net Margin % — 9,4
Rev Growth 5Y % — 5,8
D/E — 0,5

ETFs Holding This Stock

CUSD logo CUSD CrossingBridge Ultra-Short Duration ETF
1,65% weight
MERFX MERFX
0,70% weight
MERIX MERIX
0,70% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) 5,45 M
ROE N/A ROA 2,30%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -586 272,0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,06
Interest Coverage N/A Asset Turnover N/A
Working Capital -428 415 Tangible Book Value -7,33 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 64,69 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -0,17%
Market Cap 352,43 M Enterprise Value 352,43 M
Per Share
EPS (Diluted TTM) -0,03 Revenue / Share N/A
FCF / Share -0,02 OCF / Share -0,02
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion -10,76%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024
Revenue —
Net Income -279 845,0
EPS (Diluted) -0,03
Gross Profit —
Operating Income —
EBITDA —
R&D Expenses —
SG&A Expenses —
D&A —
Interest Expense —
Income Tax —

Balance Sheet

Annual, most recent first
Metric FY2024
Total Assets 550 824,0
Total Liabilities 795 669,0
Shareholders' Equity -244 845,0
Total Debt —
Cash & Equivalents —
Current Assets 4 991,0
Current Liabilities —